- Price
- $2.54
- Day
- +9.01%
- Mkt Cap
- $474.07M
- 52W Range
- $0.48 – $3.11
- Volume
- 1.67M
- Beta
- 0.23
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
ADAR1 Capital Management LLC grew its holdings in Ovid Therapeutics (NASDAQ: OVID) by 6.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,544,113 shares of the company's stock after acquiring an additional 259,113 shares during the quarter. ADAR1 Capital Management LLC owned
Read full article
Ally Bridge Group NY LLC raised its stake in Ovid Therapeutics (NASDAQ: OVID) by 57.9% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,818,459 shares of the company's stock after buying an additional 1,033,459 shares during the quarter. Ovid Therapeutics
Read full article